Documentation centre

Averna M, Banach M, Bruckert E, Drexel H, Farnier M, Gaita D, Magni P, März W, Masana L, Mello E Silva A, Reiner Z, Ros E, Vrablik M, Zambon A, Zamorano JL, Stock JK, Tokgözoğlu LS, Catapano AL

Cardiovascular Disease Lipids/Lipoproteins Prevention

Trends in diabetes treatment and control in U.S. adults, 1999-2018.

N Engl J Med. 2021;384:2219-2228

Meal-induced inflammation: postprandial insights from the Personalised REsponses to DIetary Composition Trial (PREDICT) study in 1000 participants.

Am J Clin Nutr. 2021;114:1028-1038

Impact of postprocedural high-sensitivity C-reactive protein on lipoprotein(a)-associated cardiovascular risk with ST-segment elevation myocardial infarction with percutaneous coronary intervention.

Am J Cardiol. 2021;150:8-14

Changes in cardiovascular risk factors and cardiovascular events in the elderly population.

J Am Heart Assoc. 2021;10:e019482

Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with type 2 diabetes.

Am J Clin Nutr. 2021;113:1515-1530

Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen general population study.

Arterioscler Thromb Vasc Biol. 2021;41:2063-2075

Remnant lipoproteins as a target for atherosclerosis risk reduction.

Arterioscler Thromb Vasc Biol. 2021;41:2076-2079

Omega-3PUFA supplementation ameliorates adipose tissue inflammation and insulin-stimulated glucose disposal in subjects with obesity: A potential role for apolipoprotein E.

Int J Obes (Lond). 2021;45:1331-1341

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: Evidence from a UK primary care database.

Int J Obes (Lond). 2021;45:1249-1258

Clinical utility of the logarithmically transformed ratio of triglycerides-to- high-density lipoprotein cholesterol and its relationship with other atherosclerosis-related lipid factors in type 2 diabetes.

Metab Syndr Relat Disord. 2021;19:205-212

Usefulness of triglyceride to high-density lipoprotein ratio and alanine aminotransferase for predicting insulin resistance and metabolic syndrome in the Japanese population.

Metab Syndr Relat Disord. 2021;19:225-232

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.

Atherosclerosis. 2021;325:99-109